<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13-nanomaterials-09-01294">
 <label>13.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bouton</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Frelin</surname>
    <given-names>L.P.</given-names>
   </name>
   <name>
    <surname>Forde</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Arnold</surname>
    <given-names>G.H.</given-names>
   </name>
   <name>
    <surname>Pevsner</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Synaptotagmin I is a molecular target for lead</article-title>
  <source>J. Neurochem.</source>
  <year>2010</year>
  <volume>76</volume>
  <fpage>1724</fpage>
  <lpage>1735</lpage>
  <pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00168.x</pub-id>
  <?supplied-pmid 11259490?>
  <pub-id pub-id-type="pmid">11259490</pub-id>
 </element-citation>
</ref>
